These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34412545)

  • 1. Transfusion-related acute lung injury in a COVID-19-positive convalescent plasma recipient: a case report.
    Amrutiya V; Patel R; Baghal M; Patel B; Waykole T; Patel H; Govil S; Lo A
    J Int Med Res; 2021 Aug; 49(8):3000605211032814. PubMed ID: 34412545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convalescent plasma for COVID-19 complicated by ARDS due to TRALI.
    Wang KY; Shah P; Pierce M
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33509890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Convalescent Plasma Transfusion.
    Franchini M; Glingani C
    Mayo Clin Proc; 2021 May; 96(5):1368-1369. PubMed ID: 33958067
    [No Abstract]   [Full Text] [Related]  

  • 4. The Successful Recovery of a Critically Ill COVID-19 Patient, Following the Combination of Therapeutic Plasma Exchange and Convalescent Plasma Transfusion: A Case Report.
    Novacescu AN; Duma G; Sandesc D; Sorescu T; Licker M
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors.
    Dada A; Elhassan K; Bawayan RM; Albishi G; Hefni L; Bassi S; Sobahy T; Cupler E; AlBaz N; Wali G; Alraddadi B; Alshukairi AN
    Intervirology; 2022; 65(4):230-235. PubMed ID: 35378533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early safety indicators of COVID-19 convalescent plasma in 5000 patients.
    Joyner MJ; Wright RS; Fairweather D; Senefeld JW; Bruno KA; Klassen SA; Carter RE; Klompas AM; Wiggins CC; Shepherd JR; Rea RF; Whelan ER; Clayburn AJ; Spiegel MR; Johnson PW; Lesser ER; Baker SE; Larson KF; Ripoll JG; Andersen KJ; Hodge DO; Kunze KL; Buras MR; Vogt MN; Herasevich V; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Van Buskirk CM; Winters JL; Stubbs JR; Paneth NS; Verdun NC; Marks P; Casadevall A
    J Clin Invest; 2020 Sep; 130(9):4791-4797. PubMed ID: 32525844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.
    Huang S; Shen C; Xia C; Huang X; Fu Y; Tian L
    Med Sci Monit; 2020 Dec; 26():e928755. PubMed ID: 33264276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia.
    Figlerowicz M; Mania A; Lubarski K; Lewandowska Z; Służewski W; Derwich K; Wachowiak J; Mazur-Melewska K
    Transfus Apher Sci; 2020 Oct; 59(5):102866. PubMed ID: 32636116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADRS due to COVID-19 in midterm pregnancy: successful management with plasma transfusion and corticosteroids.
    Soleimani Z; Soleimani A
    J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3040-3043. PubMed ID: 32715804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.
    Diorio C; Anderson EM; McNerney KO; Goodwin EC; Chase JC; Bolton MJ; Arevalo CP; Weirick ME; Gouma S; Vella LA; Henrickson SE; Chiotos K; Fitzgerald JC; Kilbaugh TJ; John ARO; Blatz AM; Lambert MP; Sullivan KE; Tartaglione MR; Zambrano D; Martin M; Lee JH; Young P; Friedman D; Sesok-Pizzini DA; Hensley SE; Behrens EM; Bassiri H; Teachey DT
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28693. PubMed ID: 32885904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
    Joyner MJ; Senefeld JW; Klassen SA; Fairweather D; Wright RS; Carter RE
    Mayo Clin Proc; 2020 Dec; 95(12):2802-2803. PubMed ID: 33276849
    [No Abstract]   [Full Text] [Related]  

  • 14. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of transfusion convalescent recovery plasma in patients with coronavirus disease 2019.
    Xiao K; Lin Y; Fan Z; Wen Y; Huang H; Wang M; Ren D; Wu C; Liu W; Zhang Z; Li G; LE A
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):565-570. PubMed ID: 32879108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of immunocompromised COVID-19 patients with convalescent plasma.
    Fung M; Nambiar A; Pandey S; Aldrich JM; Teraoka J; Freise C; Roberts J; Chandran S; Hays SR; Bainbridge E; DeVoe C; Roque Gardner A; Yokoe D; Henrich TJ; Babik JM; Chin-Hong P
    Transpl Infect Dis; 2021 Apr; 23(2):e13477. PubMed ID: 32989856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What convalescent plasma in treating severe acute respiratory infections of viral aetiology can hint for COVID-19? Evidence from a meta-analysis.
    Zeng J; Yin S; Du X; Song T; Lin T
    Transfus Clin Biol; 2021 Aug; 28(3):321-329. PubMed ID: 33839301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of convalescent plasma for treatment of coronavirus disease 2019 patients].
    Chen S; Lu C; Li P; Wang L; Wang H; Yang Q; Chen-Li Y; Li J; Ma H; Sang Q; Xu L; Li J; Zhang Y; Kang Y; Xing L; Zhang G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1293-1298. PubMed ID: 33463485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
    Ahn JY; Sohn Y; Lee SH; Cho Y; Hyun JH; Baek YJ; Jeong SJ; Kim JH; Ku NS; Yeom JS; Roh J; Ahn MY; Chin BS; Kim YS; Lee H; Yong D; Kim HO; Kim S; Choi JY
    J Korean Med Sci; 2020 Apr; 35(14):e149. PubMed ID: 32281317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.